People · Operator
Named in public records as an officer, director or promoter · active 2022–2023 · Other Health Care, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nucleus Radiopharma, Inc. | — | Other Health Care | Series C | $72.1M | $662.9M | 2022 |
| Phase3.io Inc. | — | Software / Tech | Series A | $4.9M | $35.1M | 2023 |
Chris McDonald at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chris McDonald on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tyrell Rivers | 1 | 6 |
| Justin Butler | 1 | 5 |
| Adam Burrows | 1 | 3 |
| Michael Rossi | 1 | 2 |
| Norman Sharpless | 1 | 2 |
| Charles Conroy | 1 | 1 |
| Yakeia Nicole Phelon | 1 | 1 |
| Aaron Dix | 1 | 1 |
| Mary Kate Wold | 1 | 1 |
| Manu Nair | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.